Treatment of Pediatric Migraine

被引:22
|
作者
O'Brien, Hope L. [1 ,2 ]
Kabbouche, Marielle A. [1 ,2 ]
Kacperski, Joanne [1 ,2 ]
Hershey, Andrew D. [1 ,2 ]
机构
[1] Cincinnati Childrens Hosp Med Ctr, Div Neurol, Cincinnati, OH 45229 USA
[2] Univ Cincinnati, Coll Med, Cincinnati, OH 45267 USA
关键词
Pediatric migraine; Primary headache; Treatment; NSAIDs; Triptans; Dopamine antagonists; DHE; Nutraceuticals; Chronic migraine; DOUBLE-BLIND; CHILDHOOD MIGRAINE; EMERGENCY-DEPARTMENT; PHARMACOLOGICAL-TREATMENT; SODIUM VALPROATE; DOSE RIBOFLAVIN; NASAL SPRAY; PLACEBO; CHILDREN; PROPHYLAXIS;
D O I
10.1007/s11940-014-0326-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The diagnosis of migraine in the pediatric population is increasing as providers are becoming more familiar with recognizing the condition. Over-the-counter and migraine-specific treatment, once considered off-label, have proven to be effective, especially if given at the early onset of head pain. Mild to severe cases of migraine should be treated with nonsteroidal anti-inflammatory drugs (NSAIDs), with triptans used alone or in combination in moderate to severe headaches unresponsive to over-the-counter therapy. Rescue medication including dihydroergotamine (DHE), a potent vasoconstrictor should be used for intractable migraines and is preferred in the hospital setting. Anti-emetics that have anti-dopaminergic properties can be helpful in patients with associated symptoms of nausea and vomiting along with headache, especially when used in combination therapy. Preventative treatment should be initiated early in patients with frequent headaches to improve headache outcomes and quality of life. Patients and families should be educated on non-pharmacologic management, such as lifestyle modification and avoidance of triggers, that can prevent progression and worsening of migraine.
引用
收藏
页码:1 / 17
页数:17
相关论文
共 50 条
  • [31] Increase in The Cost of Migraine Headache Treatment in Pediatric Hospitals
    Santiago, Jason
    Kafle, Maheshwor
    Mirea, Lucia
    Gage, Sandra
    PEDIATRICS, 2021, 147 (03)
  • [32] Newly Approved Agents for the Treatment and Prevention of Pediatric Migraine
    Kacperski, Joanne
    Hershey, Andrew D.
    CNS DRUGS, 2016, 30 (09) : 837 - 844
  • [33] Is Pediatric Migraine always Migraine? Neuromuscular Treatment as Alternative to Drug Therapy? - Case Study
    Trouw, M.
    von Piekartz, H.
    MANUELLE THERAPIE, 2009, 13 (05) : 182 - 189
  • [34] Pediatric migraine
    Lewis, Donald W.
    PEDIATRICS IN REVIEW, 2007, 28 (02) : 43 - 52
  • [35] Pediatric Migraine
    Shah, Ubaid Hameed
    Kalra, Veena
    INTERNATIONAL JOURNAL OF PEDIATRICS, 2009, 2009
  • [36] Pediatric Migraine
    Lewis, Donald W.
    NEUROLOGIC CLINICS, 2009, 27 (02) : 481 - +
  • [37] PEDIATRIC MIGRAINE
    HEDGES, TR
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1983, 95 (06) : 844 - 845
  • [38] Intravenous magnesium sulphate for treatment of pediatric migraine: case series
    Ghanem, Hytham
    Wilson, Priya T.
    Gill, Davinder S.
    SIGNA VITAE, 2023, 19 (06) : 194 - 200
  • [39] Prophylactic Treatment of Pediatric Migraine: Is There Anything New in the Last Decade?
    Papetti, Laura
    Ursitti, Fabiana
    Moavero, Romina
    Ferilli, Michela Ada Noris
    Sforza, Giorgia
    Tarantino, Samuela
    Vigevano, Federico
    Valeriani, Massimiliano
    FRONTIERS IN NEUROLOGY, 2019, 10
  • [40] Beyond pain control: Outcome and treatment preferences in pediatric migraine
    Khayata, Matthew J.
    Farley, Samantha
    Davis, J. Kelly
    Hornik, Christoph P.
    Reeve, Bryce B.
    Rikhi, Aruna
    Gelfand, Amy A.
    Szperka, Christina L.
    Kessel, Shirley
    Pezzuto, Tara
    Hammett, Alex
    Lemmon, Monica E.
    HEADACHE, 2022, 62 (05): : 588 - 595